Pieris Pharma (NASDAQ: PIRS) disclosed that on October 5, 2016, it entered into a Sales Agreement with Cowen and Company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE